Terns Pharmaceuticals (TERN) Free Cash Flow (2020 - 2023)
Historic Free Cash Flow for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to -$19.4 million.
- Terns Pharmaceuticals' Free Cash Flow fell 7216.54% to -$19.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$67.4 million, marking a year-over-year decrease of 3656.65%. This contributed to the annual value of -$70.1 million for FY2024, which is 387.89% down from last year.
- Terns Pharmaceuticals' Free Cash Flow amounted to -$19.4 million in Q4 2023, which was down 7216.54% from -$20.7 million recorded in Q3 2023.
- In the past 5 years, Terns Pharmaceuticals' Free Cash Flow registered a high of -$6.3 million during Q3 2020, and its lowest value of -$20.7 million during Q3 2023.
- Over the past 4 years, Terns Pharmaceuticals' median Free Cash Flow value was -$11.2 million (recorded in 2022), while the average stood at -$11.8 million.
- Per our database at Business Quant, Terns Pharmaceuticals' Free Cash Flow crashed by 8582.35% in 2021 and then surged by 556.49% in 2022.
- Over the past 4 years, Terns Pharmaceuticals' Free Cash Flow (Quarter) stood at -$7.4 million in 2020, then tumbled by 46.21% to -$10.9 million in 2021, then dropped by 3.46% to -$11.2 million in 2022, then tumbled by 72.17% to -$19.4 million in 2023.
- Its Free Cash Flow stands at -$19.4 million for Q4 2023, versus -$20.7 million for Q3 2023 and -$13.0 million for Q2 2023.